These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16875893)

  • 41. Approach to management of atrial fibrillation in the Indian scenario.
    Vora A
    J Assoc Physicians India; 2007 Apr; 55 Suppl():30-2. PubMed ID: 18368864
    [No Abstract]   [Full Text] [Related]  

  • 42. New directions in the management of atrial fibrillation.
    Grace A
    Lancet; 2002 Feb; 359(9304):410. PubMed ID: 11844520
    [No Abstract]   [Full Text] [Related]  

  • 43. Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence.
    Ellis K; Wazni O; Marrouche N; Martin D; Gillinov M; McCarthy P; Saad EB; Bhargava M; Schweikert R; Saliba W; Bash D; Rossillo A; Erciyes D; Tchou P; Natale A
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):799-802. PubMed ID: 17593230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiarrhythmic drugs in the era of atrial fibrillation ablation.
    Boriani G; Mei DA; Imberti JF
    Europace; 2024 Jun; 26(6):. PubMed ID: 38700094
    [No Abstract]   [Full Text] [Related]  

  • 45. Atrial fibrillation is the most common sustained arrhythmia.
    Ruskin JN; Keane D
    Semin Interv Cardiol; 1997 Dec; 2(4):181-3. PubMed ID: 9704351
    [No Abstract]   [Full Text] [Related]  

  • 46. Catheter ablation of atrial fibrillation.
    Callahan TD; Di Biase L; Horton R; Sanchez J; Gallinghouse JG; Natale A
    Cardiol Clin; 2009 Feb; 27(1):163-78, x. PubMed ID: 19111772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lessons from catheter ablation: how a proarrhythmic effect has become a therapeutic chance. The case of class IC/III drugs in atrial flutter.
    Catanzariti D; Vergara G
    Ital Heart J; 2005 Jul; 6(7):591-4. PubMed ID: 16274022
    [No Abstract]   [Full Text] [Related]  

  • 48. [Atrial fibrillation].
    Schueller PO; Steiner S; Hennersdorf MG
    Med Monatsschr Pharm; 2009 Jun; 32(6):204-10; quiz 211-2. PubMed ID: 19554830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistent pulmonary vein isolation: the elusive goal of atrial fibrillation ablation.
    Gerstenfeld EP
    J Cardiovasc Electrophysiol; 2007 Apr; 18(4):399-401. PubMed ID: 17394454
    [No Abstract]   [Full Text] [Related]  

  • 50. Catheter Ablation for Atrial Fibrillation in 2019.
    Upadhyay GA; Alenghat FJ
    JAMA; 2019 Aug; 322(7):686-687. PubMed ID: 31429886
    [No Abstract]   [Full Text] [Related]  

  • 51. [Long term drug therapy for the prevention of recurrence in atrial fibrillation].
    Newman D; Gillis A; Gilbert M; Dorian P
    Can J Cardiol; 1996 Feb; 12 Suppl A():21A-26A. PubMed ID: 8673948
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical assessment of antiarrhythmic agents for paroxysmal atrial fibrillation guided by modification of electrophysiologic arrhythmogenicity.
    Cosío FG
    J Cardiovasc Electrophysiol; 2005 Jun; 16(6):677; author reply 677. PubMed ID: 15946374
    [No Abstract]   [Full Text] [Related]  

  • 53. Who, when and how to rate control for atrial fibrillation.
    Rienstra M; Van Gelder IC
    Curr Opin Cardiol; 2008 Jan; 23(1):23-7. PubMed ID: 18281823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regular supraventricular tachycardias associated with idiopathic atrial fibrillation.
    Gonzalez-Zuelgaray J; Perez A
    Am J Cardiol; 2006 Nov; 98(9):1242-4. PubMed ID: 17056338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circumferential ablation with pulmonary vein isolation in permanent atrial fibrillation.
    Cheema A; Dong J; Dalal D; Marine JE; Henrikson CA; Spragg D; Cheng A; Nazarian S; Bilchick KC; Almasry I; Sinha S; Scherr D; Halperin H; Berger R; Calkins H
    Am J Cardiol; 2007 May; 99(10):1425-8. PubMed ID: 17493473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dronedarone: in quest of the ideal antiarrhythmic drug.
    Kayser SR
    Prog Cardiovasc Nurs; 2007; 22(4):221-4. PubMed ID: 18059201
    [No Abstract]   [Full Text] [Related]  

  • 57. How safe is the antiarrhythmic drug therapy in atrial fibrillation?
    Krishnamoorthy S; Lip GY
    Europace; 2009 Jul; 11(7):837-9. PubMed ID: 19546182
    [No Abstract]   [Full Text] [Related]  

  • 58. [Antiarrhythmic drug therapy for atrial fibrillation].
    Zhang JR; Li CY; Ma CS
    Zhonghua Nei Ke Za Zhi; 2021 Apr; 60(4):289-293. PubMed ID: 33765695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ablation of atrial fibrillation in congestive heart failure.
    Tung R; Boyle NG
    Minerva Cardioangiol; 2008 Dec; 56(6):653-7. PubMed ID: 19092740
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac resynchronization therapy in the setting of permanent atrial fibrillation and heart failure.
    Koneru JN; Steinberg JS
    Curr Opin Cardiol; 2008 Jan; 23(1):9-15. PubMed ID: 18281821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.